Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods – Mediflex Industries Pty Ltd - 194616

Overview

The Therapeutic Goods Act 1989, enacted in 1989, governs the regulation of therapeutic goods, including medical devices, in Australia. This Act aims to ensure that therapeutic goods available in Australia are of acceptable quality and safe for consumers. In 2013, a gazette, C2013G00501, was issued under section 41GP of the Act to address the problem of non-compliance by sponsors of medical devices with regulatory requirements. The gazette notifies the cancellation of an entry from the Australian Register of Therapeutic Goods for a specific surgical procedure kit, highlighting the sponsor's failure to provide necessary information as required by the Act. The enacting body, the Parliament of Australia, established this legislative framework with the policy objective of safeguarding public health by maintaining high standards for therapeutic goods available in the Australian market.

Scope and Application

The Therapeutic Goods Act 1989 applies to entities and individuals involved in the sponsorship, manufacturing, and distribution of therapeutic goods, including medical devices, within Australia. This Act governs the regulation of therapeutic goods to ensure their safety, quality, and efficacy, and encompasses a broad range of activities and transactions related to these goods. The Act applies to sponsors, manufacturers, importers, and suppliers of therapeutic goods, as well as entities that perform activities such as clinical trials and research. Geographically, the Act has national jurisdiction, applying across all states and territories in Australia. However, the Act does not apply to therapeutic goods that are exempt under the regulations, such as those used solely for personal use or research purposes, or to goods that are covered by other specific legislation. Additionally, the Act can extend its application through subordinate instruments, which may provide further details and specific requirements for certain types of therapeutic goods or industry practices. The cancellation of an entry from the Australian Register of Therapeutic Goods, as outlined in this particular Gazette, demonstrates the Act’s enforcement mechanisms to ensure compliance with regulatory standards.

Key Provisions

Section 41GP of the Therapeutic Goods Act 1989 (the Act) outlines the procedures for the publication of the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). This particular notice involves the cancellation of the entry for a surgical procedure kit, general purpose, single use, non-medicated, with an ARTG number of 194616, sponsored by Mediflex Industries Pty Ltd and manufactured by Paojiang Industrial Zone Shaoxing Zhejiang (China). The cancellation took effect on 6 May 2013 due to the sponsor's failure to comply with a notice under section 41JA of the Act, which required the provision of information relating to the device. The Act imposes obligations on sponsors of medical devices, requiring them to provide information to the Secretary as directed. Failure to comply with such notices can lead to the cancellation of the device's entry from the ARTG, as seen in this case. The sponsor, Mediflex Industries Pty Ltd, did not meet the required obligations, resulting in the cancellation of the listed surgical procedure kit. This cancellation ensures that only devices that meet the necessary regulatory requirements remain available for use in Australia. Breaches of the requirements under the Therapeutic Goods Act 1989 can result in serious consequences. In this instance, the failure of the sponsor to provide the necessary information led to the cancellation of the ARTG entry, effectively removing the device from the market. There are no specified penalties within the text for this particular breach, but generally, non-compliance with the Act can lead to further regulatory actions, including fines and potential legal proceedings. These actions are intended to enforce adherence to the regulatory standards set forth by the Act and to protect public health and safety.